Study to Evaluate the Effect of Celecoxib on the Efficacy and Safety of Amlodipine in Subjects With Hypertension Requiring Antihypertensive Therapy
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 152 participants.
Also called NCT02172040
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 152 participants
- Sponsor
- Kitov Pharmaceuticals, Ltd.
- Registry
-
NCT02172040 -
2013-005381-19
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT02172040. Randomized; triple masking; primary purpose treatment. Start 2014-06-26 (actual); primary completion 2015-11-19 (actual). Results posted on 2017-10-03.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study to Evaluate the Effect of Celecoxib on the Efficacy and Safety of Amlodipine in Subjects With Hypertension Requiring Antihypertensive Therapy
- Condition
- Hypertension
- Intervention (Drug)
- Over-encapsulated 10 mg amlodipine besylate tablet
- Intervention (Drug)
- Matched placebo capsule for over-encapsulated celecoxib capsule
- Intervention (Drug)
- Over-encapsulated 200 mg celecoxib capsule
- Intervention (Drug)
- Matched placebo capsule for over-encapsulated amlodipine besylate tablet
- Lead sponsor
- Kitov Pharmaceuticals, Ltd.
Record details
- Record id
cardio:ct-nct02172040- Content hash
6e803c5b77634947d66313598e30b3b1c3dc50a833ab4eab1e2ac4332b628cde